A CTLA-4 nanobody improves the immunity of mice against challenges with Staphylococcus aureus and Streptococcus agalactiae
Wu, P.; Yang, N. n.; Xu, M. g.; chen, c.
Show abstract
Cytotoxic T lymphocyte associated antigen 4 (CTLA-4), also known as CD152, is a transmembrane receptor and leukocyte differentiation antigen on T cells that participates in the negative regulation of immune responses. CTLA-4 Ig can effectively and specifically inhibit cellular and humoral immune responses in vivo and in vitro, and is therefore, considered to be a promising new immunosuppressive antibody. In this study, we investigated the role of CTLA-4 nanobody in immunity. We purified recombinant CTLA-4 protein and constructed a phage display nanobody library. After screening the library, we obtained a nanobody with high affinity for the CTLA-4 protein. The nanobody was expressed and purified and the specific high-affinity for CTLA-4 confirmed by enzyme-linked immunosorbent assay. The nanobody was shown to enhance the activity and nitric oxide (NO) production of bone marrow derived dendritic cells (DCs) as well as their ability to capture foot-and-mouth disease virus (FMDV). The CTLA-4 nanobody also improved the immunity of animals after challenge with Staphylococcus aureus and Streptococcus agalactiae, thus indicating the potential of the CTLA-4 nanobody to improve cellular immunity and enhance immune responses.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Selection of Human Single Domain Antibodies (sdAb) Against Thymidine Kinase 1 and Their Incorporation Into sdAb-Fc Antibody Constructs For Potential Use In Cancer Therapy 95%
- Epidemiological survey of serum titers from adults against various Gram-negative bacterial V-antigens 94%
- Adherent and suspension baby hamster kidney cells have a different cytoskeleton and surface receptor repertoire 94%
Similar papers in this journal
- Shrimp Hemocyanin elicits a potent humoral response in mammals and is favorable to hapten conjugation 95%
- Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice 95%
- SARS-CoV-2-induced humoral immunity through B cell epitope analysis and neutralizing activity in COVID-19 infected individuals in Japan 94%
Similar papers in this journal
- Isolation of a nanobody specific to the PstS-1 protein and evaluation of its immunoreactivity with structural components of Mycobacterium tuberculosis granuloma 95%
- Omicron booster in ancestral strain vaccinated mice augments protective immunities against both the Delta and Omicron variants 94%
- SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications 94%
Similar papers in this journal
- A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants 94%
- Targeting plasmid-encoded proteins that contain immunoglobulin-like domains to combat antimicrobial resistance. 93%
- Differential immune response induced by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.